Laurino Grossi

1.2k total citations
31 papers, 485 citations indexed

About

Laurino Grossi is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, Laurino Grossi has authored 31 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 12 papers in Gastroenterology and 10 papers in Epidemiology. Recurrent topics in Laurino Grossi's work include Helicobacter pylori-related gastroenterology studies (15 papers), Gastroesophageal reflux and treatments (8 papers) and Veterinary medicine and infectious diseases (7 papers). Laurino Grossi is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (15 papers), Gastroesophageal reflux and treatments (8 papers) and Veterinary medicine and infectious diseases (7 papers). Laurino Grossi collaborates with scholars based in Italy, United States and Australia. Laurino Grossi's co-authors include Leonardo Marzio, Kevin J. McHugh, Stephen M. Collins, Antonio Francesco Ciccaglione, Luigina Cellini, Simona Capodicasa, Lamberto Manzoli, Domenico Lapenna, Emanuela Di Campli and Sonia Toracchio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Laurino Grossi

30 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurino Grossi Italy 13 288 199 104 55 54 31 485
Christianna Kreiss Switzerland 15 471 1.6× 230 1.2× 116 1.1× 138 2.5× 84 1.6× 22 942
Mitsuo Nakaya Japan 9 162 0.6× 250 1.3× 19 0.2× 70 1.3× 30 0.6× 13 542
Anna Maria Magistà Italy 8 285 1.0× 327 1.6× 28 0.3× 66 1.2× 30 0.6× 9 532
Hisako Arai Japan 6 191 0.7× 305 1.5× 15 0.1× 80 1.5× 28 0.5× 10 557
Adesola Odunayo United States 11 121 0.4× 62 0.3× 84 0.8× 50 0.9× 17 0.3× 45 394
Cindy James Canada 8 164 0.6× 193 1.0× 7 0.1× 19 0.3× 64 1.2× 9 420
Małgorzata Płonka Poland 11 213 0.7× 86 0.4× 24 0.2× 46 0.8× 12 0.2× 24 358
A. Saggioro Italy 10 264 0.9× 293 1.5× 17 0.2× 38 0.7× 11 0.2× 30 629
N. Bucci Italy 4 164 0.6× 242 1.2× 8 0.1× 38 0.7× 24 0.4× 7 377
O. Pieramico Germany 15 409 1.4× 261 1.3× 20 0.2× 115 2.1× 5 0.1× 39 632

Countries citing papers authored by Laurino Grossi

Since Specialization
Citations

This map shows the geographic impact of Laurino Grossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurino Grossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurino Grossi more than expected).

Fields of papers citing papers by Laurino Grossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurino Grossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurino Grossi. The network helps show where Laurino Grossi may publish in the future.

Co-authorship network of co-authors of Laurino Grossi

This figure shows the co-authorship network connecting the top 25 collaborators of Laurino Grossi. A scholar is included among the top collaborators of Laurino Grossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurino Grossi. Laurino Grossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mocci, Giammarco, Arianna Cingolani, Carla Felice, et al.. (2023). Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason. SHILAP Revista de lepidopterología. 2. 1218228–1218228. 1 indexed citations
2.
Conti, Chiara, et al.. (2021). Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients. Frontiers in Psychiatry. 12. 664088–664088. 10 indexed citations
3.
4.
Viola, Anna, Giuseppe Costantino, Fabrizio Bossa, et al.. (2017). Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study. World Journal of Gastrointestinal Pharmacology and Therapeutics. 8(2). 131–131. 3 indexed citations
5.
Grossi, Laurino. (2015). Typical and atypical symptoms of gastro esophageal reflux disease: DoesHelicobacter pyloriinfection matter?. World Journal of Gastrointestinal Pharmacology and Therapeutics. 6(4). 238–238. 3 indexed citations
6.
Ciccaglione, Antonio Francesco, Luigina Cellini, Laurino Grossi, Lamberto Manzoli, & Leonardo Marzio. (2015). A Triple and Quadruple Therapy with Doxycycline and Bismuth for First‐Line Treatment of Helicobacter pylori Infection: A Pilot Study. Helicobacter. 20(5). 390–396. 17 indexed citations
7.
Giulio, Mara Di, Emanuela Di Campli, Soraya Di Bartolomeo, et al.. (2015). In vitroantimicrobial susceptibility ofHelicobacter pylorito nine antibiotics currently used in Central Italy. Scandinavian Journal of Gastroenterology. 51(3). 263–269. 31 indexed citations
8.
Amitrano, María, et al.. (2008). 140 Effect of Three Different Regimens with Esomeprazole, Amoxicillin, and Moxifloxacin in the Treatment of Primary H. pylori Infection. Gastroenterology. 134(4). A–24. 1 indexed citations
9.
10.
Grossi, Laurino, et al.. (2004). Premedication with Tramadol in Patients Undergoing Colonoscopy: A Double-Blind Randomized Placebo-Controlled Study. Digestive Diseases and Sciences. 49(10). 1641–1645. 4 indexed citations
11.
Cellini, Luigina, Leonardo Marzio, Giuseppina Ferrero, et al.. (2001). Transmission of Helicobacter pylori in an Animal Model. Digestive Diseases and Sciences. 46(1). 62–68. 11 indexed citations
12.
Ciccaglione, Antonio Francesco, Laurino Grossi, Alessandra Ferri, et al.. (2001). Effect of GABA8 agonist baclofen on gastro-esophageal reflux in normal subjects and patients with gastro-esophageal reflux disease: A 48-h pH-metric esophageal-gastric study. Gastroenterology. 120(5). A34–A34. 1 indexed citations
13.
Grossi, Laurino, et al.. (2001). Transient Lower Esophageal Sphincter Relaxations and Gastroesophageal Reflux Episodes in Healthy Subjects and GERD Patients During 24 Hours. Digestive Diseases and Sciences. 46(4). 815–821. 24 indexed citations
14.
Ciccaglione, Antonio Francesco, et al.. (2000). Short- and Long-Term Effect of Glyceryl Trinitrate (GTN) Ointment 0.2% and 2% on Anal Canal Pressure in Patients with Chronic Anal Fissures. Digestive Diseases and Sciences. 45(12). 2352–2356. 10 indexed citations
15.
Ferri, Alessandra, et al.. (2000). Gastric emptying of a solid-liquid meal measured with 13C octanoic acid breath test and real-time ultrasonography: a comparative study. The American Journal of Gastroenterology. 95(11). 3097–3100. 30 indexed citations
16.
17.
Marzio, Leonardo, et al.. (1996). Increase of swallows before onset of phase III of migrating motor complex in normal human subjects. Digestive Diseases and Sciences. 41(3). 522–527. 7 indexed citations
18.
Marzio, Leonardo, et al.. (1994). Migrating motor complex recorded spontaneously and induced by motilin and erythromycin in an ex vivo rabbit intestinal preparation. Peptides. 15(6). 1067–1077. 19 indexed citations
19.
Grossi, Laurino, Kevin J. McHugh, & Stephen M. Collins. (1993). On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology. 104(4). 1049–1056. 93 indexed citations
20.
Cellini, Luigina, Leonardo Marzio, Arturo Di Girolamo, et al.. (1991). Enhanced clearing ofHelicobacter pyloriafter omeprazole plus roxithromycin treatment. FEMS Microbiology Letters. 84(3). 255–258. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christianna Kreiss Breakdown of academic impact, for papers by Mitsuo Nakaya Breakdown of academic impact, for papers by Anna Maria Magistà Breakdown of academic impact, for papers by Hisako Arai Breakdown of academic impact, for papers by Adesola Odunayo Breakdown of academic impact, for papers by Cindy James Breakdown of academic impact, for papers by Małgorzata Płonka Breakdown of academic impact, for papers by A. Saggioro Breakdown of academic impact, for papers by N. Bucci Breakdown of academic impact, for papers by O. Pieramico
Rankless by CCL
2026